DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
(Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 31, 2023 | (Q4)Jan 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 1.92%159M | 62.26%86M | 69.77%219M | 495.35%512M | 128.95%174M | 1,460.00%156M | 378.95%53M | 578.95%129M | -17.31%86M | 466.61%76M |
Net income from continuing operations | 119.75%16M | 126.13%29M | 66.39%-40M | 56.44%-355M | 71.24%-44M | 61.24%-81M | 47.14%-111M | 51.03%-119M | 3.89%-815M | 36.46%-153M |
Operating gains losses | 11.11%-16M | ---- | ---- | -10,500.00%-106M | -1,600.00%-15M | ---18M | -4,100.00%-42M | -3,000.00%-31M | 87.50%-1M | 142.83%1M |
Depreciation and amortization | 4.76%22M | 16.67%21M | -16.00%21M | -26.32%84M | -20.00%20M | -25.00%21M | -41.94%18M | -16.67%25M | 5.56%114M | -20.30%25M |
Deferred tax | 100.00%2M | -350.00%-5M | 0.00%1M | -14.29%6M | -33.33%2M | -50.00%1M | 0.00%2M | --1M | 216.67%7M | -60.56%3M |
Other non cash items | 13.33%34M | 24.14%36M | 26.92%33M | 20.62%117M | 6.67%32M | 25.00%30M | 26.09%29M | 30.00%26M | -36.18%97M | -28.44%30M |
Change In working capital | -209.68%-34M | -211.11%-140M | 0.00%53M | 871.43%54M | 150.00%15M | 247.62%31M | -32.35%-45M | 26.19%53M | -105.00%-7M | -65.20%6M |
-Change in receivables | -180.65%-87M | 29.29%-70M | 31.41%251M | 9.20%-79M | -37.25%-140M | 47.46%-31M | -52.31%-99M | 37.41%191M | 50.29%-87M | 29.87%-102M |
-Change in prepaid assets | 69.23%22M | -1,100.00%-12M | -438.46%-70M | -146.15%-32M | -244.44%-31M | 750.00%13M | -109.09%-1M | 0.00%-13M | -85.71%-13M | 27.16%-9M |
-Change in payables and accrued expense | -21.05%45M | -160.47%-26M | 113.64%3M | 311.90%89M | 131.43%11M | 147.83%57M | 616.67%43M | 38.89%-22M | -153.85%-42M | -196.77%-35M |
-Change in other current assets | 0.00%6M | -16.67%5M | -16.67%5M | -14.81%23M | -16.67%5M | -14.29%6M | -14.29%6M | -14.29%6M | 17.39%27M | -6.77%6M |
-Change in other current liabilities | 11.11%-8M | 10.00%-9M | 10.00%-9M | -14.71%-39M | 16.67%-10M | 0.00%-9M | -100.00%-10M | -25.00%-10M | -41.67%-34M | -78.57%-12M |
-Change in other working capital | -140.00%-12M | -275.00%-28M | -28.28%-127M | -35.21%92M | 13.92%180M | -126.32%-5M | 33.33%16M | -110.64%-99M | -42.04%142M | 13.55%158M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 1.92%159M | 62.26%86M | 69.77%219M | 495.35%512M | 128.95%174M | 1,460.00%156M | 378.95%53M | 578.95%129M | -17.31%86M | 466.61%76M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -595.00%-99M | -68.48%156M | -428.81%-194M | 439.23%441M | -60.24%-133M | -9.09%20M | 2,505.26%495M | 167.05%59M | 64.58%-130M | 47.10%-83M |
Capital expenditure reported | -33.33%-4M | -50.00%-3M | 20.00%-4M | -66.67%-15M | -400.00%-5M | -50.00%-3M | 33.33%-2M | -66.67%-5M | -125.00%-9M | 39.47%-1M |
Net PPE purchase and sale | 66.67%-1M | -150.00%-5M | ---1M | 33.33%-8M | 0.00%-3M | -50.00%-3M | 0.00%-2M | --0 | 7.69%-12M | 58.33%-3M |
Net intangibles purchase and sale | ---- | ---- | ---- | 50.00%-1M | --0 | ---- | ---- | ---- | ---2M | --0 |
Net business purchase and sale | --0 | --0 | -154.55%-56M | -450.00%-22M | --0 | --0 | --0 | -450.00%-22M | 98.14%-4M | --0 |
Net investment purchase and sale | -448.15%-94M | -67.13%164M | -254.65%-133M | 572.82%487M | -58.23%-125M | 3.85%27M | 1,896.00%499M | 214.67%86M | 23.70%-103M | 46.73%-79M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -595.00%-99M | -68.48%156M | -428.81%-194M | 439.23%441M | -60.24%-133M | -9.09%20M | 2,505.26%495M | 167.05%59M | 64.58%-130M | 47.10%-83M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -99.25%-265M | 84.13%-50M | 88.65%-37M | -1,939.58%-883M | -878.57%-109M | -2,316.67%-133M | -1,469.57%-315M | -6,620.00%-326M | -46.07%48M | -54.18%14M |
Net issuance payments of debt | -81.82%-240M | 88.20%-40M | --0 | ---937M | ---134M | ---132M | ---339M | ---332M | --0 | --0 |
Proceeds from stock option exercised by employees | 8,900.00%88M | -141.67%-10M | -716.67%-37M | 12.50%54M | 78.57%25M | -116.67%-1M | 4.35%24M | 20.00%6M | -46.07%48M | -54.14%14M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -99.25%-265M | 84.13%-50M | 88.65%-37M | -1,939.58%-883M | -878.57%-109M | -2,316.67%-133M | -1,469.57%-315M | -6,620.00%-326M | -46.07%48M | -54.18%14M |
Net cash flow | ||||||||||
Beginning cash position | 41.85%522M | 145.52%329M | 26.20%342M | -0.73%271M | 57.53%408M | 62.83%368M | -34.31%134M | -0.73%271M | -39.20%273M | -33.09%259M |
Current changes in cash | -576.74%-205M | -17.60%192M | 91.30%-12M | 1,650.00%70M | -1,071.43%-68M | 13.16%43M | 913.04%233M | -115.63%-138M | 102.30%4M | 106.20%7M |
Effect of exchange rate changes | 133.33%1M | 0.00%1M | -200.00%-1M | 116.67%1M | -60.00%2M | 40.00%-3M | 200.00%1M | 120.00%1M | -200.00%-6M | 432.01%5M |
End cash Position | -22.06%318M | 41.85%522M | 145.52%329M | 26.20%342M | 26.20%342M | 57.53%408M | 62.83%368M | -34.31%134M | -0.73%271M | -0.73%271M |
Free cash flow | 3.36%154M | 59.18%78M | 72.58%214M | 674.60%488M | 130.56%166M | 2,383.33%149M | 296.00%49M | 1,140.00%124M | -27.59%63M | 1,440.44%72M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |